Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability

2001 • 1,006 citations

Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy

1993 • 673 citations

Preoperative Proton MR Spectroscopic Imaging of Brain Tumors: Correlation with Histopathologic Analysis of Resection Specimens

2001 • 369 citations

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy.

1993 • 354 citations

Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases

1999 • 314 citations

Probable Alzheimer disease: diagnosis with proton MR spectroscopy.

1995 • 295 citations

Early proton magnetic resonance spectroscopy in normal-appearing brain correlates with outcome in patients following traumatic brain injury

2000 • 272 citations

Magnetic resonance spectroscopy in AD

2001 • 257 citations

Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease

1994 • 217 citations

Evidence for cellular damage in normal-appearing white matter correlates with injury severity in patients following traumatic brain injury: A magnetic resonance spectroscopy study

2000 • 213 citations

Proton MR spectroscopy for the evaluation of brain injury in asphyxiated, term neonates.

1999 • 194 citations

Quantitative proton MRS predicts outcome after traumatic brain injury

1999 • 186 citations

Proton MR spectroscopy after acute central nervous system injury: outcome prediction in neonates, infants, and children.

1997 • 178 citations

Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy.

1991 • 171 citations

Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV patients

1999 • 167 citations

Gastric tumors: radiologic-pathologic correlation and accuracy of T staging with dynamic CT.

1992 • 166 citations

Comparative Diagnostic Utility of Different MR Modalities in Mild Cognitive Impairment and Alzheimer’s Disease

2002 • 160 citations

1H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors

2003 • 157 citations

Proton Magnetic Resonance Spectroscopy for the Diagnosis and Management of Cerebral Disorders

1999 • 156 citations

Brain lesions in patients with AIDS: H-1 MR spectroscopy.

1995 • 153 citations

What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

1994 • 148 citations

Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease

2005 • 145 citations

Predictive value of proton magnetic resonance spectroscopy in pediatric closed head injury

2000 • 144 citations

Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis

1996 • 136 citations

Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy.

1996 • 133 citations

Multislice proton magnetic resonance spectroscopic imaging in X‐linked adrenoleukodystrophy

1994 • 122 citations

Proton MR Spectroscopy of the Brain in Infants

1990 • 114 citations

Early brain proton magnetic resonance spectroscopy and neonatal neurology related to neurodevelopmental outcome at 1 year in term infants after presumed hypoxic–ischaemic brain injury

1999 • 112 citations

From magnetic resonance spectroscopy to classification of tumors. A review of pattern recognition methods

1998 • 108 citations

Age-Related Differences in Care Preferences, Treatment Decisions, and Clinical Outcomes of Seriously Ill Hospitalized Adults: Lessons from SUPPORT

2017 • 108 citations

Clinical experience with ¹³C MRS in vivo

2003 • 107 citations

Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy

2002 • 99 citations

Quantitative Proton Magnetic Resonance Spectroscopy of Childhood Adrenoleukodystrophy

1998 • 90 citations

Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma

2004 • 88 citations

Increased glial metabolites predict increased working memory network activation in HIV brain injury

2003 • 88 citations

Prognostic value of 1H-MRS in perinatal CNS insults

1997 • 84 citations

Proton Magnetic Resonance Spectroscopy: The New Gold Standard for Diagnosis of Clinical and Subclinical Hepatic Encephalopathy?

1996 • 84 citations

Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors.

1999 • 79 citations

¹H‐magnetic resonance spectroscopy—determined cerebral lactate and poor neurological outcomes in children with central nervous system disease

1997 • 72 citations

Prospective Utility of Cerebral Proton Magnetic Resonance Spectroscopy in Monitoring HIV Infection and Its Associated Neurological Impairment

1994 • 64 citations

Prognostic Value of Proton Magnetic Resonance Spectroscopy in Ischemic Stroke

1998 • 63 citations

Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children.

1996 • 60 citations

Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children

1998 • 58 citations

In vivo magnetic resonance spectroscopy of human fetal neural transplants

1999 • 52 citations

Could assessment of glioma methylene lipid resonance byin vivo¹H-MRS be of clinical value?

2003 • 51 citations

Clinical Utility of Muscle MR Spectroscopy

2000 • 46 citations

Added Value of Automated Clinical Proton MR Spectroscopy of the Brain

1995 • 43 citations

Short-Echo Time Proton MR Spectroscopy in the Presence of Gadolinium

2001 • 42 citations

Role of short TE 1H-MR spectroscopy in monitoring of post-operation irradiated patients

1999 • 41 citations

Clinical brain proton magnetic resonance spectroscopy for management of Alzheimer's and sub-cortical ischemic vascular dementia in older people

2002 • 37 citations

Early brain proton magnetic resonance spectroscopy and neonatal neurology related to neurodevelopmental outcome at 1 year in term infants after presumed hypoxic–ischaemic brain injury

1999 • 37 citations

Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part II: Clinical analysis.

1996 • 36 citations

1h-mr spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors

2003 • 36 citations

The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.

2003 • 35 citations

Magnetic Resonance Spectroscopy in a 9-Day-Old Heterozygous Female Child with Creatine Transporter Deficiency

2003 • 35 citations

1H-MR-Spektroskopie von Hirntumoren im Verlauf der Strahlentherapie: Anwendung von schneller spektroskopischer Bildgebung und Einzelvolumen-MRS in der Rezidivdiagnostik

2002 • 33 citations

Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy

2001 • 31 citations

Early cerebral proton MRS and neurodevelopmental outcome in infants with cystic leukomalacia

1997 • 31 citations

Membrane phospholipids and high-energy metabolites in childhood ataxia with CNS hypomyelination

2003 • 31 citations

Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy

2004 • 30 citations

The value of new magnetic resonance techniques in multiple sclerosis

2000 • 24 citations

Proton magnetic resonance spectroscopy (1H-MRS) for the evaluation of treatment of brain tumours

1995 • 24 citations

Usefulness of Single Voxel Proton MR Spectroscopy in the Evaluation of Hippocampal Sclerosis

2000 • 22 citations

Activation of Neurotransplants in Humans

1999 • 22 citations

Real or Imaginary? Human Metabolism through Nuclear Magnetism

2000 • 17 citations

Evaluation of automated MR spectroscopy: application in Alzheimer disease.

1995 • 16 citations

Advances in Newborn Screening for Metabolic Disorders: What the Pediatrician Needs to Know

2000 • 15 citations

Utility of cerebral proton magnetic resonance spectroscopy in differential diagnosis of HIV-related dementia

1995 • 13 citations

2003 Mammographic presentation and local failure analysis in patients with stage I and II breast cancer treated with conservation therapy

1996 • 12 citations

Verlaufsbeobachtung bestrahlter Hirnmetastasen mittels MR-Perfusionsbildgebung und 1 H-MR-Spektroskopie

2003 • 11 citations

[Brain tumors: interest of magnetic resonance spectroscopy for the diagnosis and the prognosis].

2001 • 10 citations

Mr imaging and mr spectroscopy of brain metastases by mr perfusion

2003 • 9 citations

Magnetic Resonance Spectroscopy For Brain Tumors

2003 • 7 citations

[Brain proton magnetic resonance spectroscopy. Indications for diagnosis and follow-up of HIV-related encephalopathy in the adult].

1998 • 7 citations

Diagnosis of hepatic encephalopathy: Willin vivo proton MRS play a role?

1999 • 7 citations

[Magnetic resonance proton spectroscopy in neurooncology--preliminary report].

2001 • 6 citations

La spectroscopie 1H: une approche métabolique des tumeurs cérébrales et de leur suivi après irradiation externe

1997 • 5 citations

Lateralization and prognostic value of proton magnetic resonance spectroscopy in patients with intractable temporal lobe epilepsy.

2001 • 4 citations

[Proton MRS: a prognostic and diagnostic tool in the diagnosis of diffuse brain diseases].

2001 • 3 citations

[Possibilities in the differential diagnosis of brain neoplasms using the long and short time sequences of proton magnetic resonance spectroscopy].

2004 • 2 citations

Positron Emission Tomography, Single Photon Emission Computed Tomography, Computed Tomography, Functional Magnetic Resonance Imaging, and Magnetic Resonance Spectroscopy and for the Diagnosis and Management of Alzheimer’s Dementia

2004 • 2 citations

[Can proton magnetic resonance spectroscopy be of any value as a prognostic factor in medulloblastoma?].

2003 • 1 citations